‘Why getting fat, Doc?’ Weight gain and psychotropic medications

References

• Mason J B, Rosenberg I H. Protein-Energy Malnutrition. Harrison's principles of medicine 13th edn., K J Isselbacher, E Braunwald, J D Wilson, J B Martin, A S Fauci, D L Kasper. McGraw-Hill, New York 1994; 440–446
   Google Scholar
• Garrow J S, Webster J. Quetlet's index (W/H2) as a measure of fatness. International Journal of Obesity 1985; 9: 147–153
   PubMed Web of Science ®Google Scholar
• Expert Panel on the Identification Evaluation and Treatment of Overweight in Adults. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Clinical Nutrition 1998; 68: 899–917
   Web of Science ®Google Scholar
• Pi-Sunyer F X. Medical hazards of obesity. Annals of Internal Medicine 1993; 119: 655–660
   PubMed Web of Science ®Google Scholar
• Colditz G A, Willett W C, Rotnitzky A. Weight gain as a risk factor for clinical diabetes. Annals of Internal Medicine 1995; 122: 481–486
   PubMed Web of Science ®Google Scholar
• Willett W C, Manson J E, Rotnitzky A. Weight, weight change and coronary heart disease in women: risk within the ‘normal’ weight range. Journal of American Medical Association 1995; 273: 461–465
   PubMed Web of Science ®Google Scholar
• Huang Z, Willet W C.D, Mason J E. Body weight, weight change, and risk for hypertension in women. Annals of Internal Medicine 1998; 28: 81–88
   Web of Science ®Google Scholar
• Rexrode K M, Hennekens C H, Willett W C. A prospective study of body mass index, weight change, and risk of stroke in women. Journal of American Medical Association 1997; 277: 1539–1545
   PubMed Web of Science ®Google Scholar
• Maclure K M, Hayes K C, Colditz G A. Weight, diet, and the risk of symptomatic gallstones in middle-aged women. New England Journal of Medicine 1989; 321: 472–474
   Web of Science ®Google Scholar
• Pi-Sunyer F X. Health implications of obesity. American Journal of Clinical Nutrition 1991; 53(Suppl. 6)1595S–1603S
   PubMed Web of Science ®Google Scholar
• Huang Z, Hankinson S E, Colditz G A. Dual effects of weight and weight gain on breast cancer risk. Journal of American Medical Association 1997; 278: 1407–1411
   PubMed Web of Science ®Google Scholar
• Hubert H B, Feinleib M, McNamara P M. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968–977
   PubMed Web of Science ®Google Scholar
• Granberry M C, Fonseca V A. Insulin resistance syndrome: options for treatment. Southern Medical Journal 1999; 92: 1–24
   Web of Science ®Google Scholar
• Ravussin E. Reduced rate of energy expenditure as a risk factor for body weight gain. New England Journal of Medicine 1988; 318: 467–472
   PubMed Web of Science ®Google Scholar
• Caterson I D. Overweight and obesity. Essentials of human nutrition, J Mann, A S Truswell. Oxford University Press, Oxford 1988; 259–269
   Google Scholar
• Luo S Q, Li E T. Effects of repeated administration of serotonergic agonists on diet selection and body weight in rats. Pharmacology and Biochemistry of Behaviour 1991; 38: 495–500
   PubMed Web of Science ®Google Scholar
• Samanin R, Garattini S. The pharmacology of serotonergic drugs affecting appetite. Nutrition and the Brain, R J Wurtman, J J Wurtman. Raven, New York 1990; 8: 163–192
   Google Scholar
• Garattini S, Mennini T, Samain R. Reduction of food intake by manipulation of central serotonin: current experimental results. British Journal of Psychiatry 1989; 155(Suppl. 8)41–51
   Web of Science ®Google Scholar
• Silverstone T, Goodall E. Serotonergic mechanisms in human feeding: the pharmacological evidence. Appetite 1986; 7: 85–97
   PubMed Web of Science ®Google Scholar
• Fletcher P J. Increased food intake in satiated rats induced by the 5HT antagonists methysergide, metergloine, and ritanserin. Psychopharmacology 1988; 96: 237–242
   PubMed Web of Science ®Google Scholar
• Walsh A E, Smith K A, Oldman A D. m-Chlorophenylpiperazine decreases food intake in a test meal. Psychopharmacology 1994; 116: 120–122
   PubMed Web of Science ®Google Scholar
• Aulakh C S, Hill J L, Yoney H T. Evidence of involvement of 5-HT1c and 5-HT2 receptors in the food intake suppressant effects of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI). Psychopharmacology 1992; 109: 444–448
   PubMed Web of Science ®Google Scholar
• Howarth P H, Emanuel M B, Holgate S T. Astemizole, a potent histamine H1 receptor antagonist: effect on allergic rhinoconjunctivitis, on antigen and histamine induced skin response and relationship to serum levels. British Journal of Clinical Pharmacology 1984; 18: 1–8
   PubMed Web of Science ®Google Scholar
• Bernstein J G. Psychotropic drug induced weight gain: mechanisms and management. Clinical Neuropharmacology 1988; 11(Suppl. 1)S194–S206
   PubMed Web of Science ®Google Scholar
• Fumeron F. Polymorphisms of uncoupling protein (UCP) and B3 adrenoreceptor genes in obese people submitted to a low calorie diet. International Journal of Obesity 1996; 20: 1051–1054
   Web of Science ®Google Scholar
• Farooqu I S. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. New England Journal of Medicine 1999; 41: 879–884
   Web of Science ®Google Scholar
• Montague C T. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997; 87: 903–908
   Web of Science ®Google Scholar
• Wannamethee S G, Shaper A G, Durrington P N. Hypertension, serum insulin, obesity and the metabolic syndrome. Journal of Human Hypertension 1998; 12: 735–741
   PubMed Web of Science ®Google Scholar
• Bentsen K, Gram L, Veje A. Serum thyroid hormones and blood folic acid during monotherapy with carbamazepine or valproate. Acta Neurologia Scandinavica 1983; 67: 235–241
   PubMed Web of Science ®Google Scholar
• Bocchetta A, Bernardi F, Burrai C. The course of thyroid abnormalities during lithium treatment: a two-year follow-up study. Acta Psychiatrica Scandinavica 1992; 86: 38–41
   PubMed Web of Science ®Google Scholar
• Salata R, Klein I. Effects of lithium on the endocrine system: a review. Journal of Laboratory Clinical Medicine 1987; 110: 130–136
   PubMed Web of Science ®Google Scholar
• Vestergaard P, Poulstrup M, Schou M. Prospective studies in a lithium cohort. 3: Tremor, weight gain, diarrhoea, psychological complaints. Acta Psychiatrica Scandinavica 1988; 78: 434–441
   PubMed Web of Science ®Google Scholar
• Chong P KK. The effect of pharmacological dosages of glucocorticoids on free living total energy expenditure in man. Clinical Endocrinology 1994; 40: 577–581
   PubMed Web of Science ®Google Scholar
• Pijl H, Meinders A E. Bodyweight change as an adverse effect of drug treatment: mechanism and management. Drug Safety 1996; 14: 329–342
   PubMed Web of Science ®Google Scholar
• Fernstrom M H, Kupfer D J. Antidepressant-induced weight gain: a comparison study of four medications. Psychiatry Research 1998; 26: 265–271
   Web of Science ®Google Scholar
• Garland E J, Remick R A, Zis A P. Weight gain with antidepressants and lithium. Journal of Clinical Psychopharmacology 1988; 8: 323–330
   PubMed Web of Science ®Google Scholar
• Berken G H, Weinstein D O, Stern W C. Weight gain: a side-effect of tricyclic antidepressants. Journal of Affective Disorders 1984; 7: 133–138
   PubMed Web of Science ®Google Scholar
• Cantu T G, Korek J S. Monoamine oxidase inhibitors and weight gain. Drug Intelligence and Clinical Pharmacy 1988; 2: 755–759
   Google Scholar
• Ackerman S, Nolan L J. Bodyweight gain induced by psychotropic drugs: incidence, mechanisms and management. CNS Drugs 1998; 9: 135–151
   Web of Science ®Google Scholar
• Bakish D, Bradwejn J, Nair N. A comparison of moclobemide, amitriptyline and placebo in depression: a Canadian multi-centre study. Psychopharmacology 1992; 106(Suppl.)S98–S101
   PubMed Web of Science ®Google Scholar
• Harvey B H, Bouwer C D. Neuropharmacology of paradoxic weight gain with selective serotonin reuptake inhibitors. Clinical Neuropharmacology 2000; 23: 90–97
   PubMed Web of Science ®Google Scholar
• Fava M, Judge R, Hoog S L, Nilsson M E, Koke S C. Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment. Journal of Clinical Psychiatry 2000; 61: 863–867
   PubMed Web of Science ®Google Scholar
• Chen Y, Silverstone T. Lithium and weight gain. International Clinical Psychopharmacology 1990; 5: 217–225
   PubMed Web of Science ®Google Scholar
• Kerry R J, Liebling L I, Owen G. Weight changes in lithium responders. Acta Psychiatrica Scandinavica 1970; 46: 238–243
   PubMed Web of Science ®Google Scholar
• Johnson R E, McFarland B H. Lithium use and discontinuation in a health maintenance organisation. American Journal of Psychiatry 1996; 153: 993–1000
   PubMed Web of Science ®Google Scholar
• Elmslie J L, Silverstone J T, Mann J I, Williams S M, Romans S E. Prevalence of overweight and obesity in bipolar patients. Journal of Clinical Psychiatry 2000; 61: 179–184
   PubMed Web of Science ®Google Scholar
• Mitchell P B. The place of anticonvulsants and other putative mood stabilisers in the treatment of bipolar disorder. Australian and New Zealand Journal of Psychiatry 1999; 33:S99–S107
   PubMed Web of Science ®Google Scholar
• Davis R, Peters D H, McTavish D. Valproic acid: a reappraisal of its pharmacological properties and clinical efficacy in epilepsy. Drugs 1994; 47: 332–372
   PubMed Web of Science ®Google Scholar
• Sharpe C, Buchanan N. Juvenile myoclonic epilepsy: diagnosis, management and outcome. Medical Journal of Australia 1995; 162: 133–134
   PubMed Web of Science ®Google Scholar
• Dinesen H, Gram L, Veje A. Weight gain during treatment with valproate. Acta Neurologia Scandinavica 1984; 70: 65–69
   PubMed Web of Science ®Google Scholar
• Isojarvi J I, Laartikarnen T J, Pakarinen A J. Obesity and endocrine disorder in women taking valproate for epilepsy. Annals of Neurology 1996; 39: 579–584
   PubMed Web of Science ®Google Scholar
• Spitz M C, Deasy D N. Conversion of valproate monotherapy in non-retarded adults with primary generalised tonic-clonic seizures. Journal of Epilepsy 1991; 4: 33–38
   Google Scholar
• Mattson R H, Cramer J A, Collins J F. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalised tonic-clonic seizures in adults. New England Journal of Medicine 1992; 327: 765–771
   PubMed Web of Science ®Google Scholar
• Coxhead N, Silverstone T, Cookson J. Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder. Acta Psychiatrica Scandinavica 1992; 85: 114–118
   PubMed Web of Science ®Google Scholar
• Tartara A, Manni R, Galimberti C A. Six-year follow-up study on the efficacy and safety of vigabatrin in patients with epilepsy. Acta Neurologia Scandinavica 1992; 86: 247–251
   PubMed Web of Science ®Google Scholar
• Loeb C, Gandolfo C, Del Sette M. Single-blind, placebocontrolled multi-centre trial of vigabatrin in the treatment of epilepsy: the Italian study group on vigabatrin. Italian Journal of Neurological Science 1992; 13: 741–747
   PubMedGoogle Scholar
• Zajecka J M. Clinical issues in long-term treatment with antidepressants. Journal of Clinical Psychiatry 2000; 61(Suppl. 2)20–25
   PubMed Web of Science ®Google Scholar
• Silverstone T, Smith G, Goodall E. Prevalence of obesity in patients receiving depot antipsychotics. British Journal of Psychiatry 1988; 153: 214–217
   PubMed Web of Science ®Google Scholar
• Kraus T, Haack M, Schuld A. Body weight and leptin plasma levels during treatment with antipsychotic drugs. American Journal of Psychiatry 1999; 156: 312–314
   PubMed Web of Science ®Google Scholar
• Umbricht D S.G, Pollack S, Kane J M. Clozapine and weight gain. Journal of Clinical Psychiatry 1994; 55(Suppl. B)157–160
   PubMed Web of Science ®Google Scholar
• Bustillo J R, Bichanan R W, Irish D. Differential effect of clozapine on weight: a controlled study. American Journal of Psychiatry 1996; 153: 817–819
   PubMed Web of Science ®Google Scholar
• Weiden P, Aquila R, Standard J. Atypical antipsychotic drugs and long-term outcome in schizophrenia. Journal of Clinical Psychiatry 1996; 57(Suppl. 11)53–60
   PubMed Web of Science ®Google Scholar
• Allison D B, Mentmore J M, Heo M, Chandler L P, Cappelleri J C, Infante M C, Weiden P J. Antipsychotic-induced weight gain: a comprehensive research synthesis. American Journal of Psychiatry 1999; 156: 1686–1696
   PubMed Web of Science ®Google Scholar
• Amdisen A. Drug-produced obesity: experiences with chlorpromazine, perphenazine and clopenthixol. Danish Medical Bulletin 1964; 11: 182–189
   PubMedGoogle Scholar
• Meltzer H Y. Mechanism of action of novel antipsychotic drugs. Schizophrenia Bulletin 1991; 17: 263–287
   PubMed Web of Science ®Google Scholar
• Moore N A, Calligaro D O, Wong D T. The pharmacology of olanzapine and other new antipsychotic agents. Current Opinion Investigational Drugs 1993; 2: 281–293
   Google Scholar
• Manson J E, Willet W C, Stampfer M J. Body weight and mortality among women. New England Journal of Medicine 1995; 333: 677–685
   PubMed Web of Science ®Google Scholar
• Kazes M, Danion J M, Grange D. Eating behaviour and depression before and after antidepressant treatment: a prospective, naturalistic study. Journal of Affective Disorders 1994; 30: 193–207
   PubMed Web of Science ®Google Scholar
• Blackburn G L. Comparison of medically supervised and unsupervised approaches to weight loss and control. Annals of Internal Medicine 1993; 199: 714–718
   Web of Science ®Google Scholar
• Hanotin C, Thomas F, Jones S P. A comparison of sibutramine and dexfenfluramine in the treatment of obesity. Obesity Research 1998; 6: 285–291
   PubMedGoogle Scholar
• Davidson M H, Hauptman J, DiGirolama M. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat. Journal of American Medical Association 1999; 281: 235–242
   PubMed Web of Science ®Google Scholar
• Goldstein D J. Beneficial health benefits of modest weight loss. International Journal of Obesity and Related Metabolic Disorders 1992; 16: 397–415
   PubMed Web of Science ®Google Scholar